Rifaximina nel trattamento della malattia diverticolare: potenziale terapeutico ed economico
Antibiotics are commonly used to treat major inflammatory complications of diverticular disease, but apparently there is no rationale for the use of antibiotic therapy in uncomplicated disease, where an inflammatory component is by definition excluded. Some observations suggest a possible role of gu...
Main Authors: | Orietta Zaniolo, Mario Eandi |
---|---|
Format: | Article |
Language: | English |
Published: |
SEEd Medical Publishers
2005-03-01
|
Series: | Farmeconomia: Health Economics and Therapeutic Pathways |
Subjects: | |
Online Access: | https://journals.seedmedicalpublishers.com/index.php/FE/article/view/817 |
Similar Items
-
Pregnancy and Healthy Childbirth in a 37 Year-Old Patient with Diverticular Disease
by: P. S. Andreev, et al.
Published: (2020-12-01) -
Russian Non-Interventional Study of the Efficacy and Tolerability of Rifaximin-α Therapy in Patients with Uncomplicated Diverticular Disease under the Conditions of Outpatient Practice
by: O. S. Shifrin, et al.
Published: (2020-04-01) -
Cyclic rifaximin and soluble dietary fiber therapy for symptomatic diverticular disease: effective prevention of complications
by: E. V. Golovanova
Published: (2019-05-01) -
Eubiotic effect of rifaximin is associated with decreasing abdominal pain in symptomatic uncomplicated diverticular disease: results from an observational cohort study
by: Vladimir Ivashkin, et al.
Published: (2023-03-01) -
Neridronato nel trattamento dell’osteogenesi imperfetta: prestazioni cliniche ed economiche di un farmaco orfano
by: Orietta Zaniolo, et al.
Published: (2004-09-01)